Please assess the completion status of the following clinical trial:

Trial Title: Effect of HPV Vaccination on Women Aged 25 Years

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* resident in Florence~* invited for the first time to the cervical cancer screening in Florence~* aged 25 years~Exclusion Criteria:~-

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: 25 Years
- Healthy Volunteers: f

Study Arms:
- no HPV vaccine (Type: NO_INTERVENTION): No delivery of HPV vaccine
- HPV vaccine (Cervarix®, GlaxoSmithKline) (Type: EXPERIMENTAL): Delivery of HPV vaccine (Cervarix®, GlaxoSmithKline) at 0, 1, 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).